Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 54 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Tucatinib with trastuzumab and pertuzumab for maintenance treatment of unresectable locally advanced or metastatic HER2-positive breast cancer	Pertuzumab (Perjeta; R-1273) , Trastuzumab (Herceptin; RG-597) , Tucatinib (ONT-380)	Breast cancer	Breast Cancer	2023	View \| Download
Tucatinib with trastuzumab emtansine for treating unresectable, locally advanced or metastatic HER2 positive breast cancer	Trastuzumab Emtansine (Kadcyla; T-DM1; PRO132365) , Tucatinib (ONT-380)	Breast cancer	Breast Cancer	2022	View \| Download
Veliparib in Combination with Carboplatin and Paclitaxel for Breast Cancer – First to Third Line	Carboplatin (Paraplatin) , Paclitaxel (Taxol; paclitaxel albumin) , Veliparib (ABT-888; NSC 737664)	Breast cancer	Breast Cancer	2017	View \| Download
Vepdegestrant for previously treated locally advanced or metastatic ER+/HER2– breast cancer	Vepdegestrant (ARV-471;PF-07850327)	Breast cancer	Breast Cancer	2023	View \| Download